Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FT378
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,644
Award facts
- Contract value 100% obligated
- $6,643.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,643.79 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count packages) on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The company's broad portfolio of federal contract awards demonstrates its capability to supply an extensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for RINVOQ ER—a JAK inhibitor indicated for rheumatoid arthritis—represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems worldwide under the DLA's Pharmaceutical Prime Vendor program.
Quick answers
Who was awarded contract SPE2DR26FT378?
SPE2DR26FT378 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FT378 worth?
The government has obligated $6,644 on SPE2DR26FT378.
Is contract SPE2DR26FT378 an order under another contract?
Yes. SPE2DR26FT378 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT378 competed?
The extent of competition for SPE2DR26FT378 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award